【原美源伯根】Cencora (COR) 2019年年度报告「NYSE」.pdf

1、20 19Summary Annual Report3AmerisourceBergen Summary Annual Report 2019In This Report 4 About AmerisourceBergen 7 CEO Statement 10 Financial Highlights 12 Management Team 13 Board of Directors 14 GAAP/Non-GAAP Financial Measures 15 Corporate Information20 19Summary Annual Report4AmerisourceBergen Su

2、mmary Annual Report 2019AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies,helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care.With services ranging from dru

3、g distribution and niche premium logistics to reimbursement and pharmaceutical consulting services,AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.With over$175 billion in annual revenue,AmerisourceBergen is headquarter

4、ed in Valley Forge,PA,and employs approximately 22,000 people around the world.AmerisourceBergen is ranked#10 on the Fortune 500 list.We distribute a comprehensive offering of brand name and generic pharmaceuticals including specialty pharmaceutical products,over-the-counter healthcare products,home

5、 healthcare supplies and equipment and related services to a wide variety of healthcare providers located in the United States and select global markets.Our About AmerisourceBergen5AmerisourceBergen Summary Annual Report 2019customers include chain retail and independent pharmacies,mail order pharma

6、cies,acute care hospitals and health systems,physician practices,medical and dialysis clinics,long-term care and other alternate site pharmacies,veterinarians,and others.Additionally,we furnish healthcare providers and pharmaceutical manufacturers with an assortment of related high-value services,in